Centiva Capital LP Sells 19,341 Shares of Omnicell, Inc. (NASDAQ:OMCL)

Centiva Capital LP lessened its position in Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 79.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,049 shares of the company's stock after selling 19,341 shares during the period. Centiva Capital LP's holdings in Omnicell were worth $220,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of OMCL. Assenagon Asset Management S.A. raised its position in shares of Omnicell by 61.3% in the second quarter. Assenagon Asset Management S.A. now owns 599,928 shares of the company's stock valued at $16,240,000 after purchasing an additional 228,093 shares during the period. Federated Hermes Inc. raised its holdings in Omnicell by 1,113.6% in the 2nd quarter. Federated Hermes Inc. now owns 991,151 shares of the company's stock valued at $26,830,000 after acquiring an additional 909,480 shares during the period. Royce & Associates LP acquired a new stake in Omnicell during the third quarter worth approximately $811,000. Intech Investment Management LLC bought a new stake in shares of Omnicell during the third quarter worth approximately $753,000. Finally, Liontrust Investment Partners LLP acquired a new position in shares of Omnicell in the second quarter valued at approximately $4,066,000. 97.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently issued reports on OMCL shares. Benchmark restated a "buy" rating and issued a $48.00 price target on shares of Omnicell in a research note on Wednesday, October 9th. Bank of America reissued a "neutral" rating and set a $57.00 target price (up previously from $44.00) on shares of Omnicell in a report on Thursday, October 31st. Wells Fargo & Company upped their price target on shares of Omnicell from $30.00 to $41.00 and gave the company an "equal weight" rating in a research note on Monday, October 14th. Craig Hallum boosted their price objective on shares of Omnicell from $45.00 to $64.00 and gave the company a "buy" rating in a report on Thursday, October 31st. Finally, StockNews.com cut shares of Omnicell from a "buy" rating to a "hold" rating in a report on Tuesday. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $52.00.

Insider Buying and Selling

In other Omnicell news, Director Mark W. Parrish sold 12,000 shares of the company's stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $47.30, for a total value of $567,600.00. Following the completion of the transaction, the director now directly owns 58,427 shares in the company, valued at approximately $2,763,597.10. This represents a 17.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.64% of the stock is owned by corporate insiders.

Omnicell Price Performance

Shares of OMCL stock traded up $0.05 on Friday, hitting $46.01. 296,981 shares of the company's stock were exchanged, compared to its average volume of 535,995. Omnicell, Inc. has a 12 month low of $25.12 and a 12 month high of $55.74. The company has a 50 day moving average of $45.25 and a 200 day moving average of $38.90. The stock has a market cap of $2.13 billion, a P/E ratio of -117.46, a price-to-earnings-growth ratio of 35.72 and a beta of 0.77.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.